Post-approval studies (Phase 4)UnknownNCT05037695
What this trial is testing
SGLT-2 Inhibitors in Prevention of Post-procedural Renal and Cardiovascular Complications aFter PCI Among Patients With Diabetes Mellitus and Coronary Artery Disease: a Prospective, Randomized, Pilot Study (SAFE-PCI)
Who this might be right for
Diabetes Mellitus, Type 2Coronary Artery DiseaseAcute Kidney Injury
University of Sao Paulo General Hospital 40